Retrospective study of tetanus in 20 dogs: 1988-2004.
The case records of 20 dogs that were treated for tetanus between 1988 and 2004 were reviewed. Young, large-breed dogs were most commonly affected. Twelve dogs had a likely source of infection identified. All dogs were treated with intravenous antibiotics and supportive care, such as muscle relaxants and sedation for muscle tremors and rigidity. Sixteen dogs received tetanus antitoxin. The mortality rate was 50%. Complete recovery in survivors required approximately 1 month.
Bandt
Carsten
C
Department of Nephrology/Hemodialysis Service of the Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, California 95616, USA.
Rozanski
Elizabeth A
EA
Steinberg
Tanja
T
Shaw
Scott P
SP
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000890:Anti-Infective Agents / Q000008:administration & dosage; D003017:Clostridium tetani; D004283:Dog Diseases / Q000188:drug therapy / Q000382:microbiology* / Q000503:physiopathology*; D004285:Dogs; D005260:Female; D005440:Fluid Therapy / Q000379:methods / Q000662:veterinary; D006993:Hypnotics and Sedatives / Q000008:administration & dosage; D007155:Immunologic Factors / Q000008:administration & dosage; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage; D009465:Neuromuscular Agents / Q000008:administration & dosage; D010400:Penicillin G / Q000008:administration & dosage; D012189:Retrospective Studies; D013742:Tetanus / Q000188:drug therapy / Q000503:physiopathology / Q000662:veterinary*; D013743:Tetanus Antitoxin / Q000008:administration & dosage; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D006993:Hypnotics and Sedatives; D007155:Immunologic Factors; D009465:Neuromuscular Agents; D013743:Tetanus Antitoxin; D008795:Metronidazole; D010400:Penicillin G